UTIC Course

International Society of Oncology Pharmacy Practitioners (ISOPP) and British Oncology Pharmacy Association (BOPA) are pleased to announce this joint collaboration project – UTIC (Understanding Targeted therapies and Immunotherapies for Cancer). 

It is a learning course over five modules incorporating twenty four videos (6-8 minutes each) taking you on a journey of learning and discovery about targeted therapies and immunotherapies used for the treatment of cancer. The videos can be set to have English subtitles.

This joint collaboration was developed to support the education and learning of oncology pharmacists around the world by producing an education course that is not currently available through either the ISOPP or BOPA education offerings.

This UTIC Course has been awarded a FIP Seal. The FIP Seal for programs is awarded to professional development programs and courses and provides a visible signal of the alignment of a provider of programs with the FIP mission to advance pharmacy worldwide. It also provides an external signal of solidarity and trust as the provider of programs assures quality of their programs and courses through a self-assessment criteria. For more information on FIP or the FIP seal, visit the website.  

For a video introducing the course please click here.

The content is split into five main topic areas:

  • Cancer biology and genetics
  • Targeted cancer treatments
  • Introduction to immunotherapy
  • Immunotherapy with checkpoint inhibitors
  • Targeted treatments and immunotherapies for haematological cancers

How To Access UTIC

Access to the course is complimentary for ISOPP members. 

Not a member? Join ISOPP for No-Fee!

Once logged In as member, click on E-learning in the top green bar to access the course. 

elearning arrow.png

 

If you are an organization or company and wish to discuss collaborating with ISOPP on other projects, please get in contact: president@isopp.org 

This education program has been supported by a partial grant from Roche Products Limited and Incyte Biosciences UK Ltd. Roche Products Limited and Incyte Biosciences UK Ltd have had no control or influence over the educational content of this program.